JWBK208-11 December 8, 2007 16:3 Char Count= 0
Alimentary Tract 139
r
Grading: UK National Dataset method is based on the most poorly diff. area as:
poorly diff: i.e. diffuse / signet ring / non-cohesive tumours
other: usu. intestinal type / cohesive growth pattern
r
Grading: WHO method is based on the proportion of tumour composed of glands:
well diff: >95%
moderately diff: 50–95%
poorly diff: <50%
r
Types of gastric carcinoma other than typical intestinal-type adenocarcinoma:
signet ring carcinoma (WHO def
n
requires >50% signet ring type)
mucinous carcinoma (WHO def
n
requires >50% mucinous type)
SCC, ASC, SmCC, ChC, carcinosarcoma and spindle cell carcinoma
medullary carcinoma (>50% is poorly diff, lymphoid stroma, lack of fibrous tissue)
anaplastic carcinoma with extensive PMN infiltration
malignant rhabdoid tumour (vimentin +ve)
hepatoid (bile canaliculi & AFP +ve, typical adenocarcinoma foci elsewhere)
metastatic (very rare, may be multiple, usu. submucosal centric and arise by lymphatic or
blood spread from: melanoma, breast, thyroid, testis, lung, oesophagus and elsewhere)
Differential Diagnosis of Signet Ring Carcinoma of Stomach (esp. on Frozen Section)
r
ILC of the breast
r
Signet ring carcinoma from other 1
◦
sites: e.g. prostate, bladder, cholangiocarcinoma, etc.
r
Malakoplakia (variant with non-mineralised PAS +ve bodies), muciphages or xanthelasma
r
Signet ring lymphoma / mesothelioma / melanoma / ovarian stromal tumour / uterine leiomy-
oma/sarcoma / amphicrine MTC, signet ring morphology in CNS tumours (oligodendroglioma and
ependymoma)
Neuroendocrine Pathology of the GIT
r
The following criteria and terms relate to the upper GIT but some apply them in the colon also
r
Hindgut (rectosigmoid) carcinoids are different. They arise in the submucosa, are usu. trabecular and
poor prognostics are: invasion of muscularis propria, size >1 cm (add esp. if >2 cm), lymph/blood
vasc. invasion, tumour ulceration, mitotic count.
r
d/dg includes glomus tumour, paraganglioma and adenocarcinoma
NE cell hyperplasia
r
Def
n
: ↑ numbers of NE cells within a pre-existing gland / crypt:
r
Confined to the mucosa (by definition)
r
May be linear or nodular with nodules no wider than the width of a normal gland / crypt (sometimes
called ‘micronodules’ hence ‘micronodular hyperplasia’)
r
Each nodule surrounded by BM
r
Adenomatoid hyperplasia =≥5 micronodules close to each other with interposed BM
NE Cell Dysplasia (= pre-carcinoid)
r
Fusion of micronodules with loss of intervening BM
r
Micronodules enlarge beyond the size of a normal gland / crypt
r
Total size >0.15 mm but <0.5 mm in max.
r
± Cytological atypia
r
± Microinvasion of the lamina propria
Microcarcinoid (= Tumourlet)
r
Def
n
: NE-proliferation >0.5mm , the upper measurement limit is not defined but it must be confined
to the mucosa and not macroscopically (clinically / endoscopically) visible
Carcinoid
r
Def
n
: a well diff. NE-proliferation >0.5mm which either:
◦
1
invades the muscularis mucosae or
◦
2
is large enough to be macroscopically visible (clinically / endoscopically).
r
The following is a guide to aggressiveness but the terms ‘benign’, ‘borderline’ and ‘malignant’ are best
avoided since all carcinoids are potentially malignant
r
‘Benign’: <1cm , no angioinvasion, tumour limited to mucosa / submucosa
r
‘Borderline’: either
◦
1
<1cm with angioinvasion but limited to mucosa / submucosa or
◦
2
1–2cm, no angioinvasion, limited to mucosa / submucosa